Skip to content

Quick ratio at other companies

Amgen logo
AmgenAMGN
+0.1×
Moderna logo
ModernaMRNA
2.4×-1.8×
Royalty Pharma logo
Royalty PharmaRPRX
2.7×+1.1×
ALN
Alnylam PharmaceuticalsALNY
3.1×+0.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
2.9×-0.2×
Incyte logo
IncyteINCY
3.5×+1.6×

Other financials

Income statement

See full
Revenue$2.5M-66.7%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$22.61B+175%
Enterprise value$21.29B+157%
P/S2,736.9×+2,454×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Calculated from Roivant Sciences’s reported figures.

Based on the most recent quarter.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's quick ratio?
Roivant Sciences (ROIV) reported quick ratio of 18.4× in Q1 2026.
How has Roivant Sciences's quick ratio changed year-over-year?
Roivant Sciences's quick ratio decreased by 45.1% year-over-year, from 33.5× to 18.4×.
What is the long-term trend for Roivant Sciences's quick ratio?
Over 4 years (2021 to 2025), Roivant Sciences's quick ratio has grown at a 29.3% compound annual growth rate (CAGR), from 44.1× to 123.3×.
What does quick ratio mean?
Can the company cover short-term bills without having to sell inventory first?
How do you interpret quick ratio?
More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
How does quick ratio compare across companies?
Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.